Pharmacists in O Fallon, Missouri


77 Pharmacists found in O Fallon
male pharmacist

Richard Francis Grosch


Pharmacist
2979 Highway K, O Fallon, MO 63368
636-379-8910     636-530-3017

male pharmacist

Robert Scherbring, R.PH.


Pharmacist
20 Ofallon Sq, O Fallon, MO 63366
636-240-6610    

male pharmacist

Rodney G Stuckenschneider, RPH


Pharmacist
9495 Mexico Rd, O Fallon, MO 63366
636-379-4131     636-379-4124



male pharmacist

Russell David Meridith, RPH


Pharmacist
1490 Mexico Loop Rd E, O Fallon, MO 63366
636-978-1602    

male pharmacist

Ryan Levins, PHARMD


Pharmacist
7422 Highway N, O Fallon, MO 63368
636-625-5012     626-625-5015

female pharmacist

Shannon Carlisle, PHARMD


Pharmacist
2605 Mclean Ct, O Fallon, MO 63368
217-433-2044    

female pharmacist

Sharlene Powers


Pharmacist
7776 Winghaven Blvd, O Fallon, MO 63368
636-265-2924     636-265-1306

male pharmacist

Dr. Soheel Ahmad Khan, PHARM.D.



2979 Highway K, O Fallon, MO 63368
636-379-8910     636-530-3017

female pharmacist

Ms. Stacey L Mohn, R.PH


Pharmacist
4650 Highway K, O Fallon, MO 63368
636-329-9163     636-329-9605

female pharmacist

Mrs. Susan Raylette Barton, RPH.


Pharmacist
1307 Highway K, O Fallon, MO 63366
636-980-9300     636-978-8447

male pharmacist

Mr. Thomas Eugene Mckean Jr., R.PH.


Pharmacist
920 N Main St, O Fallon, MO 63366
636-561-7700    

male pharmacist

Tyler Cerutti, PHARMD


Pharmacist
1307 Highway K, O Fallon, MO 63366
636-980-9300     636-978-8447

female pharmacist

Yelena Landa, PHARM D


Pharmacist
7422 Highway N, O Fallon, MO 63368
636-625-5012     636-625-5015


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.